AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
PERTUZUMAB in Tunisia
1 product registered with DPM — 0 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| PERJETA Solution injectable pour perfusion / 420 mg | 6993211H | Roche Pharma (Schweiz) AG | expired | 23 Apr 2019 |
PERTUZUMAB — DPM Registration Details
DPM (Tunisia) has 1 registered product containing PERTUZUMAB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track PERTUZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.